Replies to post #434523 on Amarin Corp Plc (AMRN)

[Number sleven]

MRM, The company has been continuing its push for a global expansion. Primarily throughout Europe. It's unlikely they do that if the intent was the sale of the company. The prior management had voiced a plan. Current management made public comments about focusing on it. Do a bit of research on how many of today's pharma giants started with a single product.
Sleven,

[couldbebetter]

MRM, I always believed that AMRN had to be owned
by BP to succeed and I still believe that. Until that day
comes, I do not see sales of Vascepa taking off. (I do
hope I am wrong about that but given the performance of
Vascepa sales in Europe, the Middle-East, and China so
far I will need proof to drop my POV.) My hope for AMRN
rests on the new formulations. Will AD use them to lure in
a BP? Or, will they be laid to waste...The problem I see is
that the new formulations are best for their development to
be handled by a BP owner. BP is skilled at patent, legal, and
political protections. The sooner a BP can both build sales
and develop new formulations the better. Can AD do this?

[JRoon71]

MRM, despite the frustration with Denner and his team, it does not necessarily mean that he is going to screw us. It certainly FEELS that way. But because we have no idea what their real plan is, all we are left with is speculation based on their current activity. I'm not sure anyone (outside of his circle) really knows what the next move is. For me, it's all the "unknowns" that are far more frustrating than the stock price. I could live with the current price, if I had a good sense of what the gameplan is. At minimum, it would help investors make better, more informed decisions on their investment.